Excessive production of pro-inflammatory cytokines in the senescent brain in response to peripheral immune stimulation is thought to induce behavioral pathology, however, few studies have examined if the increase in pro-inflammatory cytokines is accompanied by an increase in cytokine signaling. Here, we focused on IL-6 as a prototypic pro-inflammatory cytokine and used phosphorylated STAT3 as a marker of IL-6 signaling. In an initial study, IL-6 mRNA and the magnitude and duration of STAT3 activation were increased in the hippocampus of senescent mice compared to adults after i.p. injection of LPS. The LPS-induced increase in STAT3 activity was ablated in aged IL-6 À/À mice, suggesting IL-6 is a key driver of STAT3 activity in the aged brain. To determine if IL-6 activated the classical or trans-signaling pathway, before receiving LPS i.p., aged mice were injected ICV with sgp130, an antagonist of the trans-signaling pathway. Importantly, the LPS-induced increases in both IL-6 and STAT3 activity in the hippocampus were inhibited by sgp130. To assess hippocampal function, aged mice were injected ICV with sgp130 and i.p. with LPS immediately after the acquisition phase of contextual fear conditioning, and immobility was assessed in the retention phase 48 h later. LPS reduced immobility in aged mice, indicating immune activation interfered with memory consolidation. However, sgp130 blocked the deficits in contextual fear conditioning caused by LPS. Taken together, the results suggest IL-6 trans-signaling is increased in the senescent brain following peripheral LPS challenge and that sgp130 may protect against infection-related neuroinflammation and cognitive dysfunction in the aged.
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Introduction
Interleukin-6 (IL-6) has a role in cognitive dysfunction. For example, immunoneutralization of IL-6 lengthened long-term potentiation (LTP) and improved spatial alternation behavior (Balschun et al., 2004 ) while IL-6-deficient mice were refractory to lipopolysaccharide (LPS)-induced deficits in working memory (Sparkman et al., 2006) . IL-6 also disrupts neurogenesis (Vallieres et al., 2002) and is up regulated in an array of neurodegenerative diseases (Gruol and Nelson, 1997; Hofmann et al., 2009; Licastro et al., 2003; Muller et al., 1998) . Furthermore, in senescence, constitutive expression of IL-6 by brain microglia is up regulated (Godbout and Johnson, 2004; Ye and Johnson, 1999, 2001 ) and during infection there is excessive production of pro-inflammatory cytokines including IL-6, leading to prolonged sickness behavior (Abraham and Johnson, 2009; Godbout et al., 2005; Huang et al., 2008) , cognitive deficits (Barrientos et al., 2006; Chen et al., 2008; Rosczyk et al., 2008) , affective disorders such as increased anxiety and depression (Godbout et al., 2008; Kiecolt-Glaser et al., 2003) , and even atrophy of neurons (Richwine et al., 2008) . These findings in rodents have led us to speculate that the acute cognitive disorders seen in older adults with an infection are due to excessive production of pro-inflammatory cytokines in the brain, although very little is known regarding the effects of aging on cytokine receptor signaling.
The IL-6 receptor is activated through two separate, but related pathways termed classical and trans-signaling. The receptor consists of two subunits: the IL-6 receptor-alpha chain (IL-6R), which binds IL-6, and the transmembrane signaling subunit, glycoprotein 130 (gp130), which is the intracellular signal transducer and is expressed across all cell types. Classical activation consists of the IL-6 ligand binding to the membrane-bound IL-6R. It is important to note that both receptor subunits (IL-6R and gp130) can be cleaved immediately before the membrane spanning region by alternative splicing or shed by proteolytic enzymes to produce a soluble receptor located in extracellular matrix. The expression of membrane-bound IL-6R is generally limited to a few cells of the immune system, while gp130 is ubiquitously expressed (Heinrich et al., 1998; Kishimoto et al., 1992) . Thus, the basis of transsignaling is the ability of soluble IL-6R (sIL-6R) to bind IL-6 in the
